Impax Laboratories (IPXL) PT Cut to $24 at Leerink Partners

August 10, 2016 7:08 AM

Leerink Partners analyst Jason Gerberry cut his price target on Impax Laboratories (NASDAQ: IPXL) to $24.00 (from $33.00) following a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found